Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.25.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Balance (in shares) at Sep. 30, 2023   15,255                
Balance at Sep. 30, 2023 $ 0 $ 153 $ 0 $ 188,218 $ 0 $ (544) $ 80 $ 127,336 $ 80 $ 315,163
Stock-based compensation expense   $ 0   2,284   0   0   2,284
Issuance of common stock under equity compensation plans, net (in shares)   132                
Issuance of common stock under equity compensation plans, net   $ 1   (1)   0   0   0
Repurchase of shares for payment of withholding taxes for vested restricted stock grants   $ 0   (240)   0   0   (240)
Repurchase of common stock (in shares)   (979)                
Repurchase of common stock   $ (10)   (27,804)   0   0   (27,814)
Exercise of stock options, net of shares exchanged for payment (in shares)   1                
Exercise of stock options, net of shares exchanged for payment   $ (0)   9   (0)   (0)   9
Other comprehensive income       0   674   0   674
Net income (loss)   0   0   0   (11,179)   (11,179)
Exercise of stock options, net of shares exchanged for payment   $ 0   (9)   0   0   (9)
Issuance of common stock under employee stock purchase plan (in shares)   10                
Issuance of common stock under employee stock purchase plan   $ 0   250   0   0   250
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   (9)                
Other comprehensive loss       0   674   0   674
Issuance of common stock under employee stock purchase plan (in shares)   10                
Issuance of common stock under employee stock purchase plan   $ 0   250   0   0   250
Balance (in shares) at Mar. 31, 2024   14,410                
Balance at Mar. 31, 2024   $ 144   162,697   130   116,237   279,208
Balance (in shares) at Dec. 31, 2023   14,939                
Balance at Dec. 31, 2023   $ 149   177,322   476   122,148   300,095
Stock-based compensation expense   $ 0   1,012   0   0   1,012
Issuance of common stock under equity compensation plans, net (in shares)   14                
Issuance of common stock under equity compensation plans, net   $ 0   0   0   0   0
Repurchase of shares for payment of withholding taxes for vested restricted stock grants   $ 0   (4)   0   0   (4)
Repurchase of common stock (in shares)   (544)                
Repurchase of common stock   $ (5)   (15,624)   0   0   (15,629)
Exercise of stock options, net of shares exchanged for payment (in shares)   1                
Exercise of stock options, net of shares exchanged for payment   $ (0)   9   (0)   (0)   9
Other comprehensive income   0   0   (346)   0   (346)
Net income (loss)   0   0   0   (5,911)   (5,911)
Exercise of stock options, net of shares exchanged for payment   0   (9)   0   0   (9)
Other comprehensive loss   $ 0   0   (346)   0   (346)
Balance (in shares) at Mar. 31, 2024   14,410                
Balance at Mar. 31, 2024   $ 144   162,697   130   116,237   279,208
Balance (in shares) at Sep. 30, 2024   14,229                
Balance at Sep. 30, 2024   $ 142   159,579   1,079   114,963   275,763
Stock-based compensation expense   $ 0   2,427   0   0   2,427
Issuance of common stock under equity compensation plans, net (in shares)   119                
Issuance of common stock under equity compensation plans, net   $ 2   (1)   0   0   1
Repurchase of shares for payment of withholding taxes for vested restricted stock grants   $ 0   (494)   0   0   (494)
Repurchase of common stock (in shares)   (351)                
Repurchase of common stock   $ (4)   (11,011)   0   0   (11,015)
Exercise of stock options, net of shares exchanged for payment (in shares)   1                
Exercise of stock options, net of shares exchanged for payment   $ 0   (12)   0   0   (12)
Other comprehensive income   0   0   (493)   0   (493)
Net income (loss)       0   0   (579)   (579)
Exercise of stock options, net of shares exchanged for payment   $ 0   12   0   0   12
Issuance of common stock under employee stock purchase plan (in shares)   11                
Issuance of common stock under employee stock purchase plan   $ 0   301   0   0   301
Repurchase of shares for payment of withholding taxes for vested restricted stock grants (in shares)   (17)                
Other comprehensive loss   $ 0   0   (493)   0   (493)
Issuance of common stock under employee stock purchase plan (in shares)   11                
Issuance of common stock under employee stock purchase plan   $ 0   301   0   0   301
Balance (in shares) at Mar. 31, 2025   13,992                
Balance at Mar. 31, 2025   $ 140   150,789   586   114,384   265,899
Balance (in shares) at Dec. 31, 2024   14,132                
Balance at Dec. 31, 2024   $ 141   154,254   (17)   113,057   267,435
Stock-based compensation expense   $ 0   1,288   0   0   1,288
Issuance of common stock under equity compensation plans, net (in shares)   14                
Issuance of common stock under equity compensation plans, net   $ 0   0   0   0   0
Repurchase of shares for payment of withholding taxes for vested restricted stock grants   $ 0   (4)   0   0   (4)
Repurchase of common stock (in shares)   (155)                
Repurchase of common stock   $ (1)   (4,738)   0   0   (4,739)
Exercise of stock options, net of shares exchanged for payment (in shares)   1                
Exercise of stock options, net of shares exchanged for payment   $ 0   (11)   0   0   (11)
Other comprehensive income   0   0   603   0   603
Net income (loss)   0   0   0   1,327   1,327
Exercise of stock options, net of shares exchanged for payment   0   11   0   0   11
Other comprehensive loss   $ 0   0   603   0   603
Balance (in shares) at Mar. 31, 2025   13,992                
Balance at Mar. 31, 2025   $ 140   $ 150,789   $ 586   $ 114,384   $ 265,899